Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2025-05-29 AGM Information
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated 29 May 2025. It references compliance with SEBI Listing Regulations, specifically Regulation 30 and 47, and mentions the publication of a newspaper advertisement regarding the 27th Annual General Meeting (AGM) scheduled for 26 June 2025. The content includes details about the AGM notice being published in newspapers and made available on the company's website. There is no substantive financial data, financial statements, or detailed report content. The document is essentially an announcement of the AGM notice publication, not the AGM materials themselves or the AGM meeting minutes. Therefore, it fits the category of AGM Information (AGM-R) as it relates to materials shared or announced for the AGM, specifically the notice advertisement under regulatory compliance.
2025-05-29 English
Appointment
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the outcome of a Board Meeting held on May 27, 2025. It informs about the approval of the 27th Annual General Meeting date, dividend recommendation, record date for dividend eligibility, and importantly, the re-appointment of an Independent Woman Director for a second term. The document references compliance with SEBI LODR Regulations and includes an annexure with detailed disclosure about the director's re-appointment. There is no financial data or detailed report content; rather, it is an announcement of board decisions and director changes. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-05-27 English
Allotment of Securities
Board/Management Information Classification · 95% confidence The document is an official communication from Indegene Limited to stock exchanges regarding the outcome of a Board Meeting held on May 27, 2025. It includes information about the approval of the 27th Annual General Meeting date, dividend recommendation, record date for dividend eligibility, and re-appointment of an Independent Director. It also references compliance with SEBI LODR Regulations and includes an annexure with details about the director's re-appointment. The document is a formal announcement of board decisions and changes, not a full report or financial statement. It fits the category of Board/Management Information (MANG) as it announces changes in the company's board of directors and related approvals. The document length (6188 characters) and content confirm it is not a brief announcement or a full annual report but a detailed board meeting outcome notice.
2025-05-27 English
Record Date
Board/Management Information Classification · 95% confidence The document is an official communication from Indegene Limited to stock exchanges regarding the outcome of a Board Meeting held on May 27, 2025. It includes information about the approval of the 27th Annual General Meeting date, dividend recommendation, record date for dividend eligibility, and the re-appointment of an Independent Director. The document references compliance with SEBI LODR Regulations and includes disclosures required under Regulation 30 related to board changes. The content focuses on board decisions and director appointments rather than full financial results or detailed reports. The document length is 6138 characters, which is sufficient for a detailed announcement but does not contain comprehensive financial statements or management discussion. Therefore, this document is best classified as Board/Management Information (MANG) because it announces changes and approvals made by the Board of Directors, including director re-appointment and dividend declaration, but it is not a full annual report, earnings release, or other financial report.
2025-05-27 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the outcome of a Board Meeting held on May 27, 2025. It informs about the approval of the 27th Annual General Meeting date, dividend recommendation, record date for dividend eligibility, and importantly, the re-appointment of an Independent Woman Director for a second term. The document references compliance with SEBI LODR Regulations and includes an annexure with detailed disclosure about the director's re-appointment. There is no detailed financial data or full report content; rather, it is an announcement of board decisions and director changes. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the schedule of meetings with investors and analysts. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is a notification of upcoming investor/analyst meetings, with no financial data, report content, or detailed presentation included. The document length is short (2110 characters), and it serves as an announcement rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-05-26 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.